Dr. Robert Princenthal, Medical Director of RadNet’s Prostate Program, joins KTLA 5 News to discuss the silent nature of prostate cancer and the paramount importance of early screening. Highlighting the misconceptions surrounding the disease, Dr. Princenthal emphasizes that early detection significantly increases survival rates, with a focus on the necessity for men to get screened starting at age 50, or 45 for those at higher risk.

Dr. Robert Princenthal, Medical Director of RadNet's Prostate Program, sheds light on the critical aspects of prostate cancer awareness and early detection. Dr. Princenthal emphasizes the importance of regular screenings, particularly for men over 50 and those with risk factors. He discusses the silent nature of prostate cancer, the role of PSA blood tests and MRIs in early detection, and the effectiveness of targeted biopsies.

Join Dr. Paul Tung as he answers your questions about prostate cancer health and screening.

Register Here

A study shows that performing MRI scans before biopsy on men with high PSA scores could reduce prostate cancer death rates by almost 20%.

According to the American Cancer Society, 1 in 8 men will be diagnosed with prostate cancer during his lifetime. Currently, prostate cancer is the second leading cause of cancer death in American men, second only to lung cancer. And yet, despite these somewhat dire statistics, success rates for prostate cancer are actually higher than many other types of cancer.

KTLA and RadNet’s Dr. Robert Princenthal, helped kick off Movemeber by bringing awareness to men’s health topics, specifically prostate health. Dr. Princenthal shed some light on prostate cancer, screening and the TULSA procedure, as well as explained the importance of men taking charge of their prostate health.